Stronger Opening

Stocks appeared set to open higher
Monday
as we head into the Thanksgiving Holiday.

Morgan Stanley downgraded Heidrick
& Struggles
(
HSII |
Quote |
Chart |
News |
PowerRating)
from Outperform to Neutral.

Eli Lily
(
LLY |
Quote |
Chart |
News |
PowerRating)
said that data on
the experimental drug duloxetine vs. a placebo and paroxetine has shown
significant results in lowering depression.

Computer Science
(
CSI |
Quote |
Chart |
News |
PowerRating)
received an
extension in its information tech contract with United Technologies
(
UTX |
Quote |
Chart |
News |
PowerRating)
.
The extension on the contract is for five years.

Goldman Sachs is bullish on
United Micro
(
UMC |
Quote |
Chart |
News |
PowerRating)
seeing the company has a number of catalysts which could
move shares, which include renewal orders of Xylinx
(
XLNX |
Quote |
Chart |
News |
PowerRating)
and Advance
Micro Devices
(
AMD |
Quote |
Chart |
News |
PowerRating)
and potentially winning the Nvidia
(
NVDA |
Quote |
Chart |
News |
PowerRating)
Xbox
graphics processor order.

Needham upgraded Flir Systems
(
FLIR |
Quote |
Chart |
News |
PowerRating)

from Buy to Strong Buy after shares fell 24% this month.

Goldman Sachs upgraded Andrx
(
ADRX |
Quote |
Chart |
News |
PowerRating)

from Market Outperform to Trading Buy. In addition, ABN Amro upgraded the company
from Hold to Buy.

Merrill Lynch initiated coverage on
Nvidia
(
NVDA |
Quote |
Chart |
News |
PowerRating)
with a Near Term Accumulate, Long Term Buy rating. Merrill
also put a 12-18 month price target of $70 on the company.

Morgan Stanley added retailer
Abercrombie & Fitch
(
ANF |
Quote |
Chart |
News |
PowerRating)
to its US Fresh Money Buy List, while removing
Oracle
(
ORCL |
Quote |
Chart |
News |
PowerRating)
from the list.

ABN Amro upgraded Lifepoint Hospitals
(
LPNT |
Quote |
Chart |
News |
PowerRating)
from Hold to Buy on positive fundamentals.

Home improvement retailer Lowe’s
(
LOW |
Quote |
Chart |
News |
PowerRating)

reported earnings for Q3 of 32 cents a share, beating analysts’ estimates by a
penny and outpacing numbers for the same quarter a year ago by 6 cents.